How AI-Driven Innovation is Revolutionizing Natural Product Drug Discovery
Natural products (NPs) dominated early drug discovery and led to several blockbuster medicines that are still saving lives today. Yet, discovering new bioactive compounds from traditionally complex natural sources is tedious, expensive and often results in a duplication of effort when identical molecules are isolated repeatedly from multiple organisms ("rediscovery"). Gangwal A et al. recently reviewed the application of ML/DL methods for tackling nature's chemical diversity.
Efficiently Mining Natural Products with AI
Natural extracts can be laborious to isolate, elucidate, and determine their bioactivity. AI can accelerate each of these steps and has begun to change the NP research workflow.
Natural Product Selection / Dereplication
Chemical "dereplication" or quickly recognizing known molecules early in the research and discovery process saves valuable time and resources. Recognition of molecular scaffolds using AI-driven spectral analysis is now possible using Deep Learning models trained on tandem MS and NMR datasets. These tools can quickly dereplicate extracts and prioritize those with novel chemistry for further study.
Bioactivity and MOA Prediction
Once a molecule has been isolated, it is crucial to understand how it interacts with biology. Understanding bioactivity and potential mechanisms-of-action (MOA) will drive NP-inspired drug discovery. Models like GNNs and CNNs have been trained to predict the bioactivity, toxicity, and PK properties of NP-like molecules, narrowing millions of possibilities to the most promising few for wet-lab experimentation. Molecular graph scans can even be used to determine which substructures are most important for desired activity.
AI-Powered De Novo Design of NP-Inspired Leads
Recent advances in Generative AI models such as VAEs and GANs have enabled De Novo Design to use NP scaffolds as inspiration. By reverse engineering the "grammar" that defines the chemical space of natural products, these models can learn to design molecules that are both novel and synthesizable, while retaining the activity of the natural lead.
Fig. 1. AI-powered natural products-inspired drug discovery strategy. (Gangwal A.; et al. 2025)
Key Insights and Strategic Findings
- Speeding up target identification for natural products
AI-powered targeted fishing strategies predict potential targets for orphan natural products based on reverse docking and deep learning similarity searches.
- Rapid structure characterization
Transformer-based deep learning models enable spectroscopic-to-structure translation pipelines, where characterization can take hours instead of weeks.
- Connecting natural products to synthetic biology
AI-powered natural products discovery aids in identifying Biosynthetic Gene Cluster (BGCs). Some AI platforms can even predict what chemical structures a microorganism will make before they're isolated experimentally.
- Integrating multi-omics data
Integration of genomics, proteomics, and metabolomics through AI links natural products to their diverse biological effects enabling full discovery of their polypharmacology.
AI Solutions for Natural Products by Protheragen MedAI
Unlocking the secrets hidden within nature's medicine chest is the key. At Protheragen MedAI, we aim to give you the AI platform you need to do just that and transform them into clinical assets.
Protheragen MedAI offers expert services to speed up all stages of natural drug discovery.
- Drug discovery & design powered by AI
Protheragen MedAI's cutting-edge generative models help you optimize natural product scaffolds with high potency and selectivity.
- Target deconvolution
Use our AI-driven reverse-screening platform to find targets for your natural extracts and demystify their mechanisms of action from the get-go.
- Virtual screening
Access virtual screening services powered by our gigantic NP-curated libraries to find hits against your toughest targets.
- Property prediction powered by AI
Know the ADMET profiles of your NP derivatives beforehand with Protheragen MedAI's predictive models. Only the most promising candidates move forward.
Partner with Protheragen MedAI to transform your natural product libraries into a high-performance pipeline of innovative medicines. Contact us today to explore how our AI solutions can empower your research.
Original Article:
- Gangwal A.; et al. (2025). How AI-Driven Innovation is Revolutionizing Natural Product Drug Discovery. Journal of medicinal chemistry. 2025, 68(4): 3948-3969.
Services Related in the Article:
